Synergistic effect of anti-T cell receptor monoclonal antibody and 15- deoxyspergualin on cardiac xenograft survival in a mouse-to-rat model

Transplantation

Volumn 69, Issue 12, 2000, Pages 2613-2621

  Haga, Manabu ^a   Tsuchida, Masanori ^a   Hirahara, Hiroyuki ^a   Watanabe, Takehiro ^a   Hayashi, Jun Ichi ^a   Watanabe, Hisami ^a   Matsumoto, Yoh ^b   Abo, Toru ^a   Eguchi, Shoji ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELL MATURATION; CONTROLLED STUDY; GRAFT SURVIVAL; HISTOPATHOLOGY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION; XENOGRAFT; XENOTRANSPLANTATION;

EID: 0034720724     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006270-00023     Document Type: Article

References (48)

1. Auchincloss H Jr. Xenogeneic transplantation. A review. Transplantation 1988; 46 (1): 1.
2. Bach FH, Robson SC, Winkler H, et al. Barriers to xenotrans-plantation. Nat Med 1995; 1 (9): 869.
3. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11 (12): 450.
4. Hasan R, Van den Bogaerde JB, Wallwork J, White DJ. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 1992; 54 (3): 408.
5. Miyagawa S, Hirose H, Shirakura R, et al. The mechanism of discordant xenograft rejection. Transplant Proc 1989; 21 (1 Pt 1): 520.
6. Bach FH, Robson SC, Ferran C, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994; 141: 5.
7. Murase N, Starzl TE, Demetris AJ, et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55 (4): 701.
8. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1 (9): 964.
9. Rosengard BR, Adachi H, Ueda K, et al. Differences in the pathogenesis of first-set allograft rejection and acute xenograft rejection as determined by sequential morphologic analysis. Journal of Heart Transplantation 1986; 5 (4): 263.
10. Valdivia LA, Monden M, Gotoh M, Nakano Y, Tono T, Mori T. Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation. Transplantation 1990; 50 (1): 132.
11. van den Bogaerde J, Aspinall R, Wang MW, et al. Induction of long-term survival of hamster heart xenografts in rats. Transplantation 1991; 52 (1): 15.
12. Cramer DV, Chapman FA, Jaffee BD, et al. The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium. Transplantation 1992; 54 (3): 403.
13. Homan W, Williams K, Fahre J, Millard P, Morris P. Prolongation of cardiac xenograft survival in rats receiving cyclosporin A. Transplantation 1981; 31 (3): 164.
14. Xiao F, Chong AS, Foster P, et al. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation 1994; 58 (7): 828.
15. Knechtle S, Halperin E, Bollinger R. Xenograft survival in two species combinations using total-lymphoid irradiation and cyclosporin. Transplantation 1987; 43 (2): 173.
16. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet 1993; 2 (8837): 65.
17. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50 (3): 366.
18. Sayegh MH, Sablinski T, Tanaka K, et al. Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Transplantation 1991; 51 (2): 296.
19. Chen Z, Cobbold S, Metcalfe S, Waldmann H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992; 22 (3): 805.
20. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAm-1 and LFA-1. Science 1992; 255 (5048): 1125.
21. Nicolls MR, Aversa GG, Pearce NW, et al. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 1993; 55 (3): 459.
22. Tsuchida M, Hirahara H, Matsumoto Y, Abo T, Eguchi S. Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor alpha beta anti-body. Transplantation 1994; 57 (2): 256.
23. Hirahara H, Tsuchida M, Watanabe T, et al. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation 1995; 59 (1): 85.
24. Umezawa H, Kondo S, Iinuma H. Structure of an antitumour antibiotic, spergualin. J Antibiot 1981; 34: 1622.
25. Iwasawa H, Kondo S, Ikeda D, Takeuchi T, Umezawa H. Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-lS-phosphate. J Antibiot 1982; 35 (12): 1665.
26. Umeda Y, Moriguchi M, Kuroda H, et al. Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino-3-hydroxyacyl moiety. J Antibiot 1985; 38 (7): 886.
27. Nishimura K, Tokunaga T. Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro. Immunology 1989; 68 (1): 66.
28. Nemoto K, Hayashi M, Abe F, Nakamura T, Ishizuka M, Umezawa H. Immunosuppressive activities of 15-deoxyspergualin in animals. J Antibiot Tokyo 1987; 40 (4): 561.
29. Nemoto K, Ito J, Abe F, Nakamura T, Takeuchi T, Umezawa H. Suppression of humoral immunity in dogs by 15-deoxyspergualin. J Antibiot Tokyo 1987; 40 (7): 1065.
30. Fujii H, Takada T, Nemoto K, et al. Deoxyspergualin directly suppresses antibody formation in vivo and in vitro. J Antibiot 1990; 43 (2): 213.
31. Kerr P, Nikolic-Paterson D, Lan H, Tesch G, Rainone S, Atokins R. Deoxyspergualin suppresses local macrophage proliferation in rat renal allograft rejection. Transplantation 1994; 58 (5): 596.
32. Nadler SG, Tepper MA, Schacter B, Mazzucco CE. Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science 1992; 258 (5081): 484.
33. Corry RJ, Cutkomp J, Oberholser JH, Kapelanski DP, Wakely E. Prolongation of allograft and xenograft survival with 15-deoxyspergualin. Transplant Proc 1989; 21 (1 Pt 1): 530.
34. Leventhal JR, Flores HC, Gruber SA, et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1992; 54 (1): 26.
35. Valdivia LA, Monden M, Gotoh M, et al. Prolonged cardiac xenograft survival by 15-deoxyspergualin combined with splenectomy. Transplant Proc 1989; 21 (1 Pt 1): 532.
36. Valdivia LA, Monden M, Gotoh M, Tono T, Nakano Y, Mon T. Suppressor cells induced by donor-specific transfusion and deoxyspergualin in rat cardiac xenografts. Transplantation 1991; 52 (4): 594.
37. Saumweber D, Singer T, Hammer C, Krombach F, Bohm D, Gokel J 15-Deoxyspergualin - a new perspective of immunosuppressive therapy in experimental xenogeneic kidney transplantation (XKTP). Transplant Proc 1989; 21 (1 Pt 1): 542.
38. Heron I. A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand 1971; 79: 366.
39. Plowman J, Harrison S, Trader M, et al. Preclinical antitumor activity and pharmacological properties of deoxyspergualin. Cancer Res 1987; 47: 685.
40. Cantrell DA, Robins RA, Baldwin RW. A comparison of membrane markers on rat cytotoxic cells. Immunology 1983; 49 (1): 139.
41. Jefferies WA, Green JR, Williams AF. Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med 1985; 162 (1): 117.
42. Langer A, Valdivia LA, Murase N, et al. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD + dull splenic B cells. Am J Pathol 1993; 143 (1): 85.
43. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307 (5947): 168.
44. Zhu X, Imamura M, Tanaka J, et al. Effects of 15-deoxyspergualin in vitro and in vivo on cytokine gene expression. Transplantation 1994; 58 (10): 1104.
45. Heidecke C, Hancock W, Westerholt S, et al. Alpha/beta-T cell-directed therapy in rat allograftrecipients. Transplantation 1996; 61 (6): 948.
46. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts; expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3 (2): 196.
47. Lin Y, Vandeputte M, Waer M. Accommodation and T-indepen" dent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 1998; 160 (1): 369.
48. Chong A. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation 1996; 62 (1): 90.